Simpler Grants.gov #FOR-FD-25-023

FDA Grant for R&D to Address Drug Shortages and Health Fraud by Outsourcing Facilities

The Food and Drug Administration (FDA) is offering a grant opportunity to support research and development by outsourcing facilities to address drug shortages and prevent health fraud. - Government Buyer: - Food and Drug Administration (FDA) - Products/Services Requested: - Research and development services focused on: - Understanding the landscape of drug shortage products, especially those vulnerable to health fraud - Identifying and developing products by outsourcing facilities to mitigate persistent drug shortages - Increasing the supply of critical medications and stabilizing the drug supply chain - OEMs and Vendors: - No specific Original Equipment Manufacturers (OEMs) or vendors are named - Unique or Notable Requirements: - Open to a wide range of eligible applicants, including higher education institutions, nonprofits, for-profit organizations, small businesses, and government entities - Foreign organizations are not eligible - No cost sharing or matching required - Total program funding is $3,000,000 with two expected awards - Place of Performance: - Food and Drug Administration (FDA)

Description

This grant aims to better understand the landscape of drug shortage products, including those vulnerable to health fraud, and identify opportunities for outsourcing facilities to meet drug shortage needs to strengthen the supply chain. Funding supports outsourcing facilities' research and development of products that mitigate persistent drug shortages to increase the supply of critical medications and stabilize the drug supply chain to prevent health fraud. Eligible applicants include a wide range of organizations such as higher education institutions, nonprofits, for-profit organizations, small businesses, and various government entities. Foreign organizations are not eligible to apply.

View original listing